Prostatype Genomics receives approximately SEK 12.5 million from subscription options
The company is conducting a targeted issuance of shares to Vator Securities AB to fulfill the top-down guarantee commitment and ensure liquidity.
Latest Prostatype Genomics News & Updates
See the latest news and media coverage for Prostatype Genomics. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer, manufacturer, and marketer of prognostic prostate cancer genetic tests
prostatypegenomics.com- Headquarters
- Stockholm, Sweden
- Founded year
- 2007
- Company type
- Public company
- Number of employees
- 9–10
- Industry
- Biotechnology & Medical Research
Last updated
Latest news about Prostatype Genomics
In short: Prostatype Genomics advanced Medicare review, posted strong 20-year data and raised SEK 12.5 million
Company announcements
Prostatype Genomics announces its first half of 2026 earnings report
Net sales reached 457 thousand Swedish kronor while operating costs declined. The company highlights progress on US clinical validation and Medicare reimbursement processes.
Prostatype Genomics completes capital raising and publishes validation study
The company completed a rights issue for SEK 47.4 million in July and published an American validation study for Prostatype in August.
Prostatype Genomics announces the outcome of its rights issue of units
The subscription rate was 79.1 percent, raising approximately 47.4 MSEK before costs.
Media coverage
Prostatype Genomics Submittes Additional Responses in the Medicare Review Process - Working Meeting Planned for November
Prostatype Genomics AB announces that this week the company submitted responses and clarifications to the latest questions in the ongoing process to secure Medicare reimbursement...
New, strong data for Prostatype® presented at a scientific congress
New data for Prostatype® have been presented at the Swedish Urological Association's annual meeting in Växjö today. The data is particularly interesting, as the follow-up...
Prostatype Genomics AB: Prostatype Genomics provides update on the Medicare process regarding Prostatype
Prostatype Genomics AB today provides an update regarding the ongoing process for Medicare reimbursement for Prostatype® in the US. The process is continuing, and the...
Prostatype raises in 12.5 million in rights issue
Life science company Prostatype Genomics has raised approximately 12.5 million SEK before deduction of transaction-related costs in connection with redemption...
Never miss news about Prostatype Genomics
Track Prostatype Genomics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Prostatype Genomics competitors & trending companies
Browse news for competitors to Prostatype Genomics and other trending companies.
A3P
Myriad
SharkNinja
NRx
Ropes & Gray
HighTech Kaunas
inretrn
Poundland
Farrer & Co
Specialfastigheter
SISAB
Hemsö
Stenvalvet
Liljewall
Veidekke
Locum
NCC
Kriminalvården
Archus
Nyréns
Peab
MVB
VGR fastigheter
AIX
ByggDialog
Tengbom
LINK
Dynacon
Delphidata
Waystream
Netnod
Open Infra
PENN Entertainment
BrandCrowd
Itancia
Paul, Weiss